Skip to main content
. 2010 Dec 8;17(3-4):163–171. doi: 10.2119/molmed.2010.00056

Figure 2.

Figure 2

Kaplan-Meier curves for DFS and OS of patients with BCL2L12 mRNA-positive and mRNA-negative nasopharyngeal tumors. BCL2L12 mRNA expression has an unfavorable prognostic value for nasopharyngeal carcinoma, since patients with BCL2L12 mRNA-positive nasopharyngeal tumors have significantly shorter DFS (P = 0.020) (A) and OS (P = 0.27) (B), compared with NPC patients with BCL2L12 mRNA-negative tumors.